Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., . . . Bajorin, D. F. (2016). Atezolizumab as first-line therapy in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial. Lancet.
Παραπομπή Chicago StyleBalar, Arjun V., et al. "Atezolizumab As First-line Therapy in Cisplatin-ineligible Patients With Locally Advanced and Metastatic Urothelial Carcinoma: A Single-arm, Multicentre, Phase 2 Trial." Lancet 2016.
Παραπομπή MLABalar, Arjun V., et al. "Atezolizumab As First-line Therapy in Cisplatin-ineligible Patients With Locally Advanced and Metastatic Urothelial Carcinoma: A Single-arm, Multicentre, Phase 2 Trial." Lancet 2016.